Membrane and intracellular platelet-activating factor receptor expression in leukemic blasts of patients with acute myeloid and lymphoid leukemia

被引:10
作者
Donnard, M [1 ]
Guglielmi, L [1 ]
Turlure, P [1 ]
Piguet, C [1 ]
Couraud, MJ [1 ]
Bordessoule, D [1 ]
Denizot, Y [1 ]
机构
[1] CHU Dupuytren, UMR CNRS 6101, Serv Pediat, Serv Hematol Clin, Limoges, France
关键词
AML; ALL; PAF receptor; blast cells; CD34(+) cells;
D O I
10.1634/stemcells.20-5-394
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Platelet-activating factor (PAF), a phospholipid mediator with a wide range of actions on mature leukocytes, acts through PAF-receptors (PAF-Rs) on the membranes of responsive cells. No results are available concerning the putative presence of PAF-Rs on leukemic blasts. Using multiparameter flow cytometry, we assessed intracellular and membrane PAF-Rs on blast cells of acute myeloid leukemic (AML) and acute lymphoid leukemic (ALL) patients. Membrane PAF-Rs were documented in 7/15 cases of ALL and 0/28 cases of AML. Putative intracellular PAF-Rs were found in blasts of 8/8 ALL and 13/13 AML patients. Vitamin D-3 and dimethyl sulfoxide that induced the expression of PAF-Rs on the membrane of the human promyelocytic leukemia cell line, HL60, failed to induce their expression on the membranes of CD34(+) AML blasts. The lack of membrane PAF-Rs on the membranes of AML blasts confirms that these receptors represent a marker of mature cells and that their membrane induction is a consequence of cell maturation and differentiation.
引用
收藏
页码:394 / 401
页数:8
相关论文
共 24 条
[1]  
Bastien Y, 1999, J IMMUNOL, V162, P5498
[2]   PAF AND HEMATOPOIESIS .3. PRESENCE AND METABOLISM OF PLATELET-ACTIVATING-FACTOR IN HUMAN BONE-MARROW [J].
DENIZOT, Y ;
TRIMOREAU, F ;
DUPUIS, F ;
VERGER, C ;
PRALORAN, V .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1995, 1265 (01) :55-60
[3]   Expression of platelet-activating factor receptor transcript-1 but not transcript-2 by human bone marrow cells [J].
Desplat, V ;
Besse, A ;
Faucher, JL ;
Praloran, V ;
Denizot, Y .
STEM CELLS, 1999, 17 (02) :121-124
[4]   Effect of platelet-activating factor on the growth of human erythroid and myeloid CD34+ progenitors [J].
Dupuis, F ;
Gachard, N ;
Allegraud, A ;
Dulery, C ;
Praloran, V ;
Denizot, Y .
MEDIATORS OF INFLAMMATION, 1998, 7 (02) :99-103
[5]  
HOWELL AL, 1990, BLOOD, V75, P721
[6]  
HWANG SB, 1991, MOL PHARMACOL, V39, P788
[7]   Agonist-induced sequestration, recycling, and resensitization of platelet-activating factor receptor - Role of cytoplasmic tail phosphorylation in each process [J].
Ishii, I ;
Saito, E ;
Izumi, T ;
Ui, M ;
Shimizu, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (16) :9878-9885
[8]   Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice [J].
Ishii, S ;
Shimizu, T .
PROGRESS IN LIPID RESEARCH, 2000, 39 (01) :41-82
[9]   Enhanced expression of platelet-activating factor receptor on human eosinophils by interleukin-3, interleukin-5 and granulocyte-macrophage colony-stimulating factor [J].
Kishimoto, S ;
Shimazu, W ;
Izumi, T ;
Shimizu, T ;
Fukuda, T ;
Makino, S ;
Sugiura, T ;
Waku, K .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1996, 111 :63-65
[10]   EFFECTS OF PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONISTS ON INTRACELLULAR PLATELET-ACTIVATING-FACTOR FUNCTION IN NEUTROPHILS [J].
KOIKE, H ;
IMANISHI, N ;
NATSUME, Y ;
MOROOKA, S .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 269 (03) :299-309